Astria Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATXS and other ETFs, options, and stocks.About ATXS
Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway.
CEOJill C. Milne
CEOJill C. Milne
Employees78
Employees78
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2008
Founded2008
Employees78
Employees78
ATXS Key Statistics
Market cap753.81M
Market cap753.81M
Price-Earnings ratio-6.01
Price-Earnings ratio-6.01
Dividend yield—
Dividend yield—
Average volume465.12K
Average volume465.12K
High today$13.22
High today$13.22
Low today$12.89
Low today$12.89
Open price$12.99
Open price$12.99
Volume296.09K
Volume296.09K
52 Week high$13.29
52 Week high$13.29
52 Week low$3.56
52 Week low$3.56
Stock Snapshot
Astria Therapeutics(ATXS) stock is priced at $13.21, giving the company a market capitalization of 753.81M. It carries a P/E multiple of -6.01.
During the trading session on 2026-01-07, Astria Therapeutics(ATXS) shares reached a daily high of $13.22 and a low of $12.89. At a current price of $13.21, the stock is +2.4% higher than the low and still -0.1% under the high.
Trading volume for Astria Therapeutics(ATXS) stock has reached 296.09K, versus its average volume of 465.12K.
The stock's 52-week range extends from a low of $3.56 to a high of $13.29.
The stock's 52-week range extends from a low of $3.56 to a high of $13.29.
Analyst ratings
88%
of 8 ratingsBuy
12.5%
Hold
87.5%
Sell
0%
People also own
Based on the portfolios of people who own ATXS. This list is generated using Robinhood data, and it’s not a recommendation.